Organizations: Department of Genetics, Washington University in St. Louis, St. Louis, MO 63110, USA · Department of Computer Science, Southern Methodist University, Dallas, TX 75205, USA · Department of Health Data Science and Artificial Intelligence, University of Texas Health Science Center at Houston, Houston, TX 77030, USA · Houston Methodist Neal Cancer Center, Houston Methodist Research Institute, Houston, TX 77030, USA · Department of Data Science and Analytics, Georgetown University, Washington, DC 20057, USA · Department of Banking and Finance, Nanyang Technological University, Singapore 639798
Interpretable glaucoma detection requires a transparent connection between fundus images, clinically meaningful biomarkers, and diagnostic predictions. Knowledge graph (KG) reasoning provides this structure, but performance measured using annotated biomarkers does not establish performance when only images are available. We present Auto-GlaKG, an automated framework that combines image-based biomarker prediction with fixed clinical-prior rules. A ResNet50 network predicts the cup-to-disc ratio (CDR) and six morphological signs using biomarker supervision, and a KG reasoner aggregates their signed rule contributions into a glaucoma score. On 689 fundus images evaluated using stratified, group-aware five-fold cross-validation, Auto-GlaKG achieves a pooled area under the receiver operating characteristic curve (AUC) of 0.951 (95% confidence interval: 0.931--0.969), with sensitivity of 0.970 and specificity of 0.779. The matched image classifier also achieves an AUC of 0.951, while the rule stage adds 0.2~ms per image. Replacing predicted CDR with its annotation increases fold-mean AUC from 0.953 to 0.995. The framework provides an explicit rule-level account of image-based predictions and identifies CDR estimation as a priority for validation using independently measured biomarkers.
Figures & tables
Fig. 1: Construction of an image-level evidence subgraph in Auto-GlaKG. Step 1: the fundus image enters the graph as an image node. Step 2: the biomarker network, trained without a diagnosis loss, predicts seven biomarkers, the CDR and six morphological signs, which become biomarker nodes. Step 3: each biomarker is linked to the clinical rules defined on it through schema-level relations, yielding ten candidate rules. Step 4: rule activations ar are computed softly from the predicted biomarkers (red: glaucoma evidence; blue: normal evidence; dashed: ar<0.5 ). Step 5: activated rules contribute strength-weighted evidence to the glaucoma-directed and normal-directed sums, whose signed difference defines the KG score s and the probability pKG . Step 6: the subgraph joins the global KG through the shared rule and biomarker nodes (the example is marked by a star). Highlighted rules and edges provide a compact visualization; all soft contributions, including those below the visualization threshold, remain in the score.
Rule
Condition
Dir.
wr
CDR high
c≥0.7
G
3
CDR moderate
0.6≤c<0.7
G
2
CDR normal
c≤0.5
N
3
Rim thinning
Present
G
3
Notching
Present
G
3
ISNT violated
Present
G
2
TABLE I: Fixed rule set. G and N indicate glaucoma-directed ( er=+1 ) and normal-directed ( er=−1 ) evidence.
Method
AUC [95% CI]
Fold AUC
AUPRC
Acc
BalAcc
Sens
Spec
Prec
F1
MCC
Brier ↓
ECE ↓
Sens@95Spec
ResNet50
0.951 [0.929, 0.970]
0.952±0.028
0.955
0.910
0.907
0.920
0.893
0.934
0.927
0.810
0.075
0.058
0.724
Auto-GlaKG (hard)
0.938 [0.914, 0.960]
0.938±0.025
0.943
0.900
0.888
0.937
0.840
0.905
0.921
0.786
0.088
0.075
0.604
Auto-GlaKG (soft)
0.951 [0.931, 0.969]
0.953±0.023
0.962
0.897
0.874
0.970
0.779
0.877
0.921
0.782
0.087
0.090
0.658
Auto-GlaKG (hard) + Image
0.949 [0.927, 0.968]
0.952±0.026
0.961
0.903
0.897
0.920
0.874
0.923
0.922
0.794
0.082
0.070
0.700
Auto-GlaKG (soft) + Image
0.946 [0.925, 0.967]
0.955±0.025
0.955
0.912
0.901
0.944
0.859
0.916
0.930
0.811
0.072
0.044
0.600
TABLE II: Diagnostic Performance on Pooled Out-of-Fold Predictions. AUC Intervals Are 95% Group-Bootstrap Confidence Intervals; Fold AUC Is Mean ± Std over the Five Test Folds. Best Value per Column in Bold (Lower Is Better for Brier and ECE). Acc: Accuracy; BalAcc: Balanced Accuracy; Sens: Sensitivity; Spec: Specificity; Prec: Precision; MCC: Matthews Correlation Coefficient; ECE: Expected Calibration Error; Sens@95Spec: Sensitivity at 95% Specificity.
Fig. 2: Rule co-activation networks. A rule is counted as activated when air≥0.5 . Node size is the activation frequency of a rule; edge width is the fraction of images in which two rules are activated together (red: both glaucoma evidence; blue: both normal evidence; grey: mixed). Annotated biomarkers yield two disjoint, near-deterministic rule families, whereas predicted biomarkers yield weaker and more heterogeneous co-activations.
Glaucoma is a leading cause of irreversible blindness worldwide, yet most automated diagnosis systems rely on opaque deep-learning models that offer little clinical interpretability. We present GlaKG, a biomarker-centric fundus knowledge graph that integrates structural biomarkers, clinically grounded rules, and image features to produce traceable reasoning for glaucoma diagnosis and risk stratification. GlaKG encodes six entity types (Fundus Image, Optic Disc, Neural Rim, Pathology, Diagnosis, Risk Level), eight relation types, and 11 clinically validated rules into a unified graph, so that every prediction is accompanied by an explicit reasoning chain linking biomarker evidence to activated clinical rules. To keep knowledge-based reasoning strictly separate from label information, we adopt a post-processing fusion framework that combines ResNet50 image embeddings with a normalized KG reasoning-chain score via a tunable weight alpha, with all fitting confined to the training split. On a publicly available, AI-annotated fundus dataset, GlaKG reaches F1 = 0.9953 for binary glaucoma classification and 0.930 accuracy with 0.922 weighted F1 for four-class risk stratification; we report openly that the dataset's biomarker annotations are highly label-correlated, and therefore frame these figures as an upper bound attainable with clean structured biomarkers rather than as leakage-free image-only performance. Feature-importance analysis shows KG-derived and biomarker features contributing near-equally (51.1% vs. 48.9%), and the reasoning chain flags borderline cases by exposing low chain scores rather than failing silently. GlaKG's central contribution is therefore a clinically auditable reasoning framework that complements raw predictive performance by explicitly exposing the biomarker evidence and rule activations behind each decision.
Cheng Huang, Jia Zhang, Yi Jiang +7
University of Texas Southwestern Medical Center · 2Southern Methodist University · 3Nanyang Technological University +1
Early and accurate glaucoma detection is critical to prevent irreversible vision loss, yet existing AI methods often rely on unimodal inputs and lack interpretability. We present GlaBoost, a multimodal gradient boosting framework that unifies three complementary signals for glaucoma risk prediction: fundus image embeddings from a pretrained convolutional encoder,free-text neuroretinal rim assessments encoded by a transformer-based language model, and structured ophthalmic biomarkers. These modalities are fused into a single representation and classified by an enhanced XGBoost model.On two real-world annotated datasets, GlaBoost consistently outperforms unimodal and generic multimodal baselines. Feature importance analysis highlights the cup-to-disc ratio, rim thinning, and the ISNT rule as the dominant predictors, yielding clinically consistent and interpretable decisions. GlaBoost offers a transparent and scalable foundation for multimodal decision support in ophthalmology.
Cheng Huang, Zeyu Han, Weizheng Xie +4
Department of Computer Science, Southern Methodist University, Dallas, TX 75205, USA · Department of Ophthalmology, UT Southwestern Medical Center, Dallas, TX 75390, USA · High Performance Computing Program, National Aeronautics and Space Administration, Washington, DC 20546, USA
While deep learning has advanced automated glaucoma screening via color fundus photography, existing purely data-driven models often overfit to confounding imaging artifacts and struggle to capture unpredictable pathological cues located beyond predefined anatomical boundaries. To address these limitations, we propose a retinal knowledge-oriented framework that synergizes dynamic multi-scale feature learning with domain-specific anatomical priors. The proposed architecture adopts a tri-branch structure to jointly model the global retinal context, the structural characteristics of the optic cup and disc, and dynamically cropped pathological regions. Specifically, we devise a Dynamic Window Mechanism (DWM) that adaptively discovers diagnostically informative patches via image-level supervision. Furthermore, we introduce a Knowledge-Enhanced Convolutional Block Attention Module (KE-CBAM) that explicitly incorporates retinal priors from a pre-trained foundation model RETFound to guide spatial attention, preventing the network from assigning spurious weights to irrelevant background noise. Extensive evaluations on the large-scale AIROGS dataset demonstrate that our method achieves a state-of-the-art AUC of 98.5% and an accuracy of 94.6%. More importantly, the integration of anatomical priors effectively mitigates the inherent class imbalance, significantly improving the detection of referable glaucoma cases. Additional validations on the SMDG-19 benchmark further confirm its superior cross-domain generalization, indicating that our contribution provides a robust, interpretable, and scalable solution for real-world clinical glaucoma diagnosis. Our code is available at https://github.com/magiczhuo/Glaucoma-Detection
Chi Liu, Yuzhuo Zhou, Sheng Shen +9
Faculty of Data Science, City University of Macau, Avenida Padre Tomás Pereira, Taipa, 999078, Macao, China · State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Vision Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, 510000, Guangdong, China · Hainan International College, Minzu University of China, Li’an International Education Innovation Pilot Zone, Lingshui, 572423, Hainan, China +4